These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening]. Sinan ÜY; Sansoy V Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358 [TBL] [Abstract][Full Text] [Related]
3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
4. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores. Miserez AR; Martin FJ; Spirk D Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060 [TBL] [Abstract][Full Text] [Related]
7. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes. Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465 [TBL] [Abstract][Full Text] [Related]
8. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results. Bourbon M; Rato Q; Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457 [TBL] [Abstract][Full Text] [Related]
13. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia. Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction. Cui Y; Li S; Zhang F; Song J; Lee C; Wu M; Chen H Clin Cardiol; 2019 Mar; 42(3):385-390. PubMed ID: 30637778 [TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting. Martín-Campos JM; Plana N; Figueras R; Ibarretxe D; Caixàs A; Esteve E; Pérez A; Bueno M; Mauri M; Roig R; Martínez S; Pintó X; Masana L; Julve J; Blanco-Vaca F; J Clin Lipidol; 2018; 12(6):1452-1462. PubMed ID: 30293936 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9. Page MM; Stefanutti C; Sniderman A; Watts GF Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720 [TBL] [Abstract][Full Text] [Related]
17. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk. Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017 [TBL] [Abstract][Full Text] [Related]
18. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study. Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL; Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616 [TBL] [Abstract][Full Text] [Related]